Quality of life of patients with inflammatory bowel disease

Abstract

Rationale Crohn's disease and non-specific ulcerative colitis are part of inflammatory bowel diseases. They have a chronic evolution, leading to important repercussions on patients’ quality of life. Measuring this subjective parameter requires an evaluation tool in clinical trials and health programs. The “Inflammatory Bowel Disease Questionnaire” is an American instrument of McMaster University, which had its reproducibility and validity determined in studies in other countries as a measure of the quality of life in IBD.

Objective To evaluate the quality of life of patients with inflammatory bowel disease through the Inflammatory Bowel Disease Questionnaire, and to correlate the results with sociodemographic data of the patients.

Methods This is a prospective cross-sectional study carried out with 58 patients; the patients’ follow-up was conducted at the outpatient clinic of Coloproctology.

Results Among the 58 patients evaluated, 70.1% had DC, 62.1% were women, the mean age was 46.08 years, 96.6% were non-smokers, and 24.1% were submitted to surgery for the underlying disease. 43% were in a combination therapy scheme, 44% in monotherapy, and 12% were not using medication. Significant change in quality of life was observed in patients taking prednisone.

Conclusion The patients with better quality of life are those who were taking prednisone. There was no other correlation with significance in the patients’ quality of life.

Resumo

Racional Faz parte das doenças inflamatórias intestinais a doença de Crohn e a Retocolite Ulcerativa Inespecífica Possuem evolução crônica, gerando repercussões importantes na qualidade de vida dos doentes. Medir esse parâmetro subjetivo requer um instrumento de avaliação em ensaios clínicos e de programas de saúde. O “Inflammatory Bowel Disease Questionnaire” é um instrumento norte-americano da McMaster University, que teve sua reprodutibilidade e validade determinada em estudos em outros países, como medida da qualidade de vida em doenças inflamatórias intestinais.

Objetivo Avaliar a qualidade de vida dos pacientes com doença inflamatória intestinal através do questionário “Inflammatory Bowel Disease Questionnaire”, e correlacionar os resultados com dados sociodemográficos dos pacientes.

Método Estudo prospectivo transversal, realizado com 58 pacientes, acompanhamento no ambulatório de Coloproctologia.

Resultados Dentre os 58 pacientes avaliados, 70,1% possuíam DC, 62,1% mulheres, idade média de 46,08 anos, 96,6% não tabagistas, 24,1% submetidos à cirurgia pela doença de base. Estavam em uso de terapia combinada 43%, monoterapia 44% e sem uso de medicamento 12%. Foi observada alteração significativa da qualidade de vida nos pacientes em uso de prednisona.

Conclusão Os pacientes com melhor qualidade de vida são os que estavam em uso de prednisona. Não houve outra correlação com significância na qualidade de vida.

Keywords

Inflammatory bowel diseases - Crohn's disease - Ulcerative colitis - Colitis - Quality of life

Palavras-chave

Doença inflamatória intestinal - Doença de Crohn - Colite ulcerativa - Colite - Qualidade de vida

Publication History

Received: 13 February 2017

Accepted: 19 June 2017

Article published online:
17 February 2021